Intra-Cellular Therapies (ITCI) – Analyst EPS View
-
Intra-Cellular Therapies (ITCI) is a Bright Spot in a Dark Earnings Season, Jefferies Reiterates Buy
-
Piper Jaffray Downgrades Intra-Cellular Therapies (ITCI) to Neutral
-
-
-
Back to ITCI Stock Lookup